This inventor holds 3 USPTO granted patents and 7 published patent applications and 1 EPO patent. Top assignees: Bristol-Myers Squibb Compnay, Halozyme, Inc.. Active years: 2006-2026.
Company Filing History:
3 out of 3,736 
1 out of 85 
Years Active: 2006-2026
Title: Innovations and Contributions of Thomas A. Haby
Introduction
Thomas A. Haby is a notable inventor based in Hillsborough, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of tumors. With a total of 3 patents to his name, Haby's work has had a meaningful impact on medical science.
Latest Patents
One of Haby's latest patents is titled "Methods of Treating Tumors." This patent focuses on a process and formulation containing epothilones and their analogs. The formulation is designed for parenteral administration, where the pH can be controlled to enhance the stability and potency of the epothilone or its analogs. This innovative approach aims to improve treatment outcomes for patients suffering from tumors.
Career Highlights
Throughout his career, Thomas A. Haby has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Bristol-Myers Squibb Company and Halozyme, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in drug formulation and treatment methodologies.
Collaborations
Haby has collaborated with several professionals in his field, including Vijay H. Naringrekar and Scott Aaron Hart. These collaborations have contributed to the advancement of his research and the successful development of his patents.
Conclusion
In summary, Thomas A. Haby is a distinguished inventor whose work in tumor treatment and drug formulation has made a significant impact in the medical field. His innovative patents and collaborations reflect his commitment to advancing healthcare solutions.